期刊文献+

国产多西他塞不同给药方案联合小剂量卡培他滨治疗转移性乳腺癌的临床疗效观察 被引量:1

The clinical effect of the combination of different dosing regimens and small dose of chemotherapy for the treatment of metastatic breast cancer
下载PDF
导出
摘要 目的观察国产多西多西他赛不同给药方案联合小剂量卡培他滨治疗转移性乳腺癌的疗效和不良毒副反应.方法:40例转移性乳腺癌患者均接受国产多西他赛联合小剂量卡培他滨方案治疗 ,20例多西他赛静脉每周给药剂量为 25mg/m2 ,第1、8、15天;卡培他滨 l000 mg,2次/ d,第1-21天.20例多西他赛三周给药剂量为75 mg/m2,第1天;卡培他滨 1000 mg,2次/d,第1-21天.评价两组的有效率及不良毒副反应.结果:每周组20例患者完全缓解 (CR)2例 , 部分缓解 (PR)5例,有效率(CR +PR)35.0% (7/20).3周组 20 例患者完全缓解(CR)2例,部分缓解 (PR )6例,有效率(CR+PR )40.0%(8/20).3周组的 III-IV度血液学毒性、胃肠道反应及脱发乏力均较每周组高,而3周组的周围神经炎及肝功能损害较每周组低.结论:多西他赛联合卡培他滨是治疗转移性乳腺癌的有效方案之一,不同给药方案耐受性不同;周剂量多西他赛联合卡培他滨治疗转移性乳腺癌的疗效确切及毒副反应轻, 患者耐受性好,值得临床推广. ObjeciveTo observe domestic Duoxiduo West he match different dosing regimen combined with small dose of card of capecitabine in the treatment of metastatic breast cancer efficacy and adverse events. Methods:40 cases of metastatic breast cancer were treated with docetaxel combined with small dose of capecitabine treatment, 20of them with weekly Docetaxel,about 25mg/m2,d1、8、15、20 of them with 3 weekly Docetaxel, about 75mg/m2, dl, both of them were given 1000mg Capecitabine, twice a day for 21days.Efficacy and toxicity were evaluated.Results:In weekly group 2 patient achieved CR.5 patients achieved PR.The response rate(RR )Was 35.0%,while in 3 weekly group 2 patient achieved CR,5patients achieved PR.The response rate(RR ) Wa s 40.0%.The IV - III hematological toxicity, gastrointestinal reaction and hair loss were higher in the three week group than in the weekly group, The peripheral neuritis and liver function damage in three weeks group than a week group. Conclusion:Docetaxel combined with card capecitabine is the treatment of metastatic breast cancer one of the most effective scheme, different regimen of tolerance to different; weekly dose docetaxel combined card of capecitabine in the treatment of metastatic breast cancer curative effect and adverse reaction of light, well tolerated by patients, it is worth clinical popularization.
出处 《世界中医药》 CAS 2015年第A02期904-905,共2页 World Chinese Medicine
关键词 多西他赛 卡培他滨 化疗 乳腺癌 Docetaxel capecitabine chemotherapy breast cancer
  • 相关文献

参考文献6

二级参考文献47

  • 1张宜勤,陆进成,翟振宇,魏青.三维适形放疗食管癌临床研究的初步结果[J].中华放射肿瘤学杂志,2005,14(1):31-34. 被引量:115
  • 2梁翠微,杨兵,李小亮,孙达春.泰素帝联合希罗达治疗晚期乳腺癌的临床观察[J].肿瘤研究与临床,2005,17(6):405-406. 被引量:8
  • 3李明毅,林大任,谭洁媚.卡培他滨联合多西紫杉醇治疗蒽环类耐药的转移性乳腺癌31例[J].中华肿瘤防治杂志,2006,13(3):216-217. 被引量:25
  • 4谢明,周建华,文继舫,蒋海英.乳腺癌基质金属蛋白酶-9及前哨淋巴结CK19 mRNA表达的相关性[J].实用医学杂志,2007,23(7):962-965. 被引量:5
  • 5Mitsumori M,Hiraoka M,Okuno Y,et al.A phase I and II clinical trial of a newly developed ultrasound hyperthennia system with an improved planar transducer[J].Int J Radiat Oncol Biol Phys,1996,36(5):1169-1175.
  • 6Hiraoka M,Nishimura Y,Masunaga S,et al.Clinical evaluation of 430 MHz microwave hyperthermia system with lens applicator for cancer therapy[J].Med Biol Eng Comput,1995,33(1):44-47.
  • 7Seidman AD.Monotherapy options in the management of metastab'c breast cancer[J].Semin Oncol,2003,30(2 Supp 1 3):6-10.
  • 8Shord SS,Faucette SR,Gillenwater HH,et al.Cemcitabine phanna-cokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer[J].Cancer Chemother Pharmacol,2003,51(4):328-336.
  • 9Rha SY,Jeung H,Kim Y,et al.Efficacy of gemcitabine as a salvage treatment in breast cancer patients refractory to anthracycline and paclintaxel based regimen[J].Proc ASC0,2002,21:A2038.
  • 10Blum JL,Dieras V,Lo Russo PM,et al.Muhleenter,phase Ⅱ study of capecitabine in taxane-pretreated metastatic breast carcinoma[J].Cancer,2001,92:1759.

共引文献127

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部